General Warning: Treatment with Azacitidine may require supportive care sufficient to protect a patient from the serious infection, bleeding, and less serious vomiting and nausea.
Azacitidine is recommended to used for the treatment of all FAB classified sorts of MDS such as:
- Refractory anemia or refractory anemia with the ringed sideroblasts (RARS).
- Refractory anemia with the excess blasts (RAEB).
- Refractory anemia in transformation (RAEB-T).
- Chronic myelomonocytic leukemia (CMML).
What is myelodysplastic syndrome?
MDS also known as Myelodysplastic syndromes, mainly are the group of such cancers in which the immature blood cells of bone marrow usually do not mature, so these immature cells remain unhealthy blood cells.
Azacitidine side effects: The most common adverse reactions reported by subcutaneous route are:
- site erythema
Most common adverse reactions reported by the intravenous route also included:
What is the best price of azacitidine?
Please contact at the Toll-free number +91 1800 889 1064 (8130290915) for AZACITIDINE price in India. Email –email@example.com We give assurance of the quality as well as delivery across the globe as per the buyer’s requirements.
Where can I buy azacitidine?
The Indian Pharma connects buyer’s with the supplier who can ship AZACITIDINE to any country of the world as per the buyer’s requirement and Government regulations of the country.
AZISHIL is manufactured by Shilpa Medicare. The Indian Pharma has several options to choose the exporter and supplier of cancer treatment medications. We offer the guarantee of the quality and delivery across the world as per the need of buyer’s.
How does an order will be confirmed?
The order for Azacitidine fda label drug only can be placed after the receipt of:
- Valid prescription of a doctor
- Import permit (if required)
Azacitidine cost: Azacitidine is a cost-friendly and inexpensive drug, available at all the registered and legitimate pharmaceutical companies. The drug is available at “The Indian Pharma” for worldwide shipping.
Dosage: Azishil (azacitidine for injection) comes as lyophilized powder in 100 mg single-use vials. Azishil’s recommended dosage for the initial treatment cycle, for all the patients regardless of the baseline hematology laboratory values, is 75 mg/m2 should be given intravenously or subcutaneously daily for the 7 days. Patients must be premedicated for vomiting and nausea.